1 Thoracic semeiologic alterations after 5 days |
2 |
109 |
Risk Difference (M‐H, Fixed, 95% CI) |
‐0.06 [‐0.13, 0.02] |
2 Thoracic semeiologic alterations after 5 days |
2 |
109 |
Risk Difference (M‐H, Random, 95% CI) |
‐0.05 [‐0.20, 0.10] |
3 Thoracic semeiologic alterations after 5 days |
2 |
109 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.14 [0.01, 2.63] |
4 Thoracic semeiologic alterations at the end of treatment (= 28 days) |
1 |
100 |
Risk Difference (M‐H, Fixed, 95% CI) |
‐0.14 [‐0.25, ‐0.03] |
4.1 Subgroup = bronchitis |
1 |
48 |
Risk Difference (M‐H, Fixed, 95% CI) |
‐0.11 [‐0.27, 0.06] |
4.2 Subgroup = tracheitis |
1 |
52 |
Risk Difference (M‐H, Fixed, 95% CI) |
‐0.17 [‐0.32, ‐0.02] |
5 Thoracic semeiologic alterations at the end of treatment (= 28 days) |
1 |
100 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.17 [0.03, 0.99] |
5.1 Subgroup = bronchitis |
1 |
48 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.26 [0.03, 2.32] |
5.2 Subgroup = tracheitis |
1 |
52 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.11 [0.01, 1.95] |